Jupiter Bioscience Of India Seeks U.S., Europe Acquisitions
This article was originally published in PharmAsia News
India's Jupiter Bioscience says it is discussing with several companies as possible acquisition targets to build its strength in the United States and Europe. The firm plans to spend about $15 million through the coming year to acquire a company in each of the two markets. Jupiter Chairman Venkat Kalavakolanu did not name firms it was talking to, but said some are high-end research companies specializing in peptides and others specialize in building-blocks. (Click here for more
You may also be interested in...
Chobani introduces Chobani Probiotic, its first functional probiotics beverage to support digestive and immune health; Danone North America extends its Danimals children’s yogurt line with products to support immune system; and Plexus Worldwide and Sofar Americas roll out children’s probiotics.
Report quantifies social media posts describing adverse events involving the Essure contraceptive device, which was pulled from the market amid safety concerns.
Deal Snapshot: The China/US CAR-T firm will be bought out by its management team and institutional investors in a deal structured as a merger into a new company.